AzTrials
AzTrials

ObeseAPP-MENCT03083964

Addressing Place and People Micro Environments in Weight Loss Disparities

A study testing Priming in people with Obese, run by Indiana University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to A) capture obesogenic cues that occur in daily life, and B) to deliver cue alerts. Investigators hypothesized that A) black women experience more cues, B) racial disparities in obesity are reduced in models that adjust for cues, and C) the priming arm will achieve a weight loss of 2kg… Read more about this study

Who is it for?
Ages 35 to 64 years, women onlyHealthy volunteers can take part
Conditions the study is for
Obese
What is being tested?
Priming
Could I receive a placebo?
No, everyone receives an active treatment
How many people
350 participants
Where
1 siteUnited States
Study dates
18 Jan 2017to 11 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 64 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Electronic Screener Data (EMR):
  • Aged 35 to 64 years.
  • Female.
  • BMI ≥ 30.
  • Healthy-Me referral or Eligible for Healthy-Me
  • Self-reported Screener Data:
Show all 9Show fewer
  • English as primary language.
  • Self-identified non-Hispanic black or African-American, or non-Hispanic white.
  • A permanent address.

Who cannot join

  • Electronic Screener Data (EMR):
  • Severe illness that might be associated with weight loss, such as cancer.
  • Use of weight loss medications (rare due to cost of the medications).
  • History of bipolar disorder or psychosis.
  • Self-reported Screener Data:
  • Severe cognitive impairment (≥3 errors on a 6-item cognitive screen).
Show all 12Show fewer
  • Unwilling or unable to provide informed consent.
  • Bariatric surgery already completed or planned within 12 months.
  • Pregnant or nursing in past 6 months, or plans to become so within 12 months.
  • Residence outside of Marion County, Indiana.
  • Substance abuse (for alcohol; ≥2 on CAGE questionnaire).
  • Current smoking or tobacco use.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Daniel Clark

    Indianapolis, Indiana, 46202

Other trials in United States

About this study

Official title: APP-ME: Addressing Place and People MicroEnvironments in Weight Loss Disparities

The purpose of this study is to A) capture obesogenic cues that occur in daily life, and B) to deliver cue alerts. Investigators hypothesized that A) black women experience more cues, B) racial disparities in obesity are reduced in models that adjust for cues, and C) the priming arm will achieve a weight loss of 2kg or more. Investigators will explore whether racial disparities in weight loss differ between the groups receiving usual care or those receiving cues.

Read the detailed description

Aim 1: After participants have been consented over the phone or in clinic, the Research Assistants (RA) will schedule a baseline assessment. Baseline interviewer administered survey questions, assessments, and equipment set-up will be completed in participants' homes to allow a physical environment assessment of the home. Assessments and surveys will be carried out using Research Electronic Data Capture (REDCap; see Resources). The in-home baseline assessment piloted for the proposed study takes 1 to 1.5 hours. Global Positioning System (GPS) locating, accelerometry, bite monitoring, and EMA surveys will operate through the mHealth app over the immediate 2-4 week period. For GPS locating, the mHealth app uses software that identifies and sends the longitude and latitude at the time of EMA response to a secure IU server. Software then determines the address of the location and whether it is the participant's home, work, restaurant, retail store, etc. For messaging, the mHealth app uses "Push Notification" to deliver EMA requests to the device (i.e., smartphone). This bypasses the phone carrier's Short Message Service (SMS) gateway, which is not always reliable or secure. The mHealth app makes sure the messages are delivered and secure. Participants receive a notification and open the application to answer the EMA questions. The database is located in a secure network within Indiana University servers. None of the data are stored inside the smartphone at rest. The actual questions are very brief with radio button responses.

At the end of the 2-4 week window, RAs will return to the home to collect the accelerometer and bite counter which takes about 1 hour. The accelerometer and bite counter are to be marked by the RA with the study participants ID and data are retrieved. At this time, participants who responded to 75% or more of the messages over the 2-4 week period, will be randomized to Usual Care (UC) or Priming Arm for Aim 2 and given instruction on the next steps of study participation. Randomization will be carried out within each race group to ensure a balance in the number of subjects between the two treatment arms. The Investigator will computer-generate randomization lists in field envelopes to be provided to the RAs for treatment assignment.

Aim 2: The second aim of the study will last 6 months. Both UC and Priming arms will have full access to Healthy-Me coaches and classes as well as receive training and access to the mHealth app. When study participation is excluded, all apps and associated data will be removed from the smartphone. At no time will Patient Health Information (PHI) be stored on the smartphone. Smartphones will only be identified by study ID number and the developer will only have access to the participants' study ID number and smartphone data collected by the mHealth app. Subjects in UC and Priming will undergo similar assessments and procedures; however, the Priming arm participants will, in addition receive 6-8 message alerts per day. The application and notifications that will be used in the Priming arm will be built from each participants own library to be delivered at times and in locations that their Aim 1 data indicate they often experience an eating or sedentary cue. In short, this intervention counters an obesogenic cue with a "healthy" prime in real-time and location.

Finally, following 6 months of UC or Priming, blinded RAs will return to participants home to complete 6-month follow-up assessment and collect all study related equipment. The final assessment and surveys will take about 1-1.5 hours and all data captured will also be carried out in REDCap.

Conditions
Obese
Being tested
Usual Care, Priming
Keywords
Middle aged women, 35-64yrs, BMI= >30
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Usual CareBehavioural

    Usual care is not considered an intervention. This arm of the study involves a lifestyle coaching intervention delivered in primary care sites to the subjects.

  • PrimingBehavioural

    The intervention is a just in time eating or physical activity reminder. Each individual participant reports physical activity goals as well as times that they most often eat. This information is used to select for that individual the best time to send an eating or physical activity reminder. The reminders come to the participant's smartphone or a study provided smartphone. Participants will receive reminder 2 to 4 times per day depending on their goals and behavior pattern.

Study groups in NCT03083964
Study groupRoleWhat they receive
Usual CareActive comparatorUsual care involves a lifestyle coaching intervention delivered in primary care sites.
Receives: Behavioral: Usual Care
PrimingExperimentalPriming involves usual care plus just in time reminder messages related to mindful eating and physical activity.
Receives: Behavioral: Priming

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of participants that lose 2 kilograms of weight between baseline and 6 month follow-up

    Participants are weighed at baseline and 6 months to access if proportion is losing 2kg of body weight or more by 6 months.

    Measured: baseline and 6 months

Secondary outcomes (4)
  1. Physical activity frequency

    Outcomes include ecological momentary assessments that query up to 12 times per day to address physical activity using smartphones.

    Measured: 6 months

  2. Eating Frequency

    Participants will self-report eating behavior for 3 week periods at baseline and follow-up at 6 month.

    Measured: 6months

  3. Depression

    Depression is measured using the patient health questionnaire PHQ-4

    Measured: 6 months

  4. Anxiety

    Anxiety is measured using the patient health questionnaire PHQ-4

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2017
  2. Study start18 Jan 2017
  3. Primary completion11 Dec 2021
  4. Study completion11 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
The participants are randomized to one of two treatment arms, usual care or intervention.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
350 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03083964
Sponsor's protocol ID
1512254890
Acronym
APP-ME
Status last verified
Nov 2023
First submitted
14 Feb 2017
Last updated
28 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Clark DO, Keith NR, Ofner S, Hackett J, Li R, Agarwal N, Tu W. Environments and situations as correlates of eating and drinking among women living with obesity and urban poverty. Obes Sci Pract. 2021 Sep 1;8(2):153-163. doi: 10.1002/osp4.557. eCollection 2022 Apr.

    PubMed 35388340
  • Srinivas P, Bodke K, Ofner S, Keith NR, Tu W, Clark DO. Context-Sensitive Ecological Momentary Assessment: Application of User-Centered Design for Improving User Satisfaction and Engagement During Self-Report. JMIR Mhealth Uhealth. 2019 Apr 3;7(4):e10894. doi: 10.2196/10894.

    PubMed 30942698

Questions about this trial

What is this clinical trial studying?

A study testing Priming in people with Obese, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of participants that lose 2 kilograms of weight between baseline and 6 month follow-up (time frame: baseline and 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03083964, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in